Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation

Affiliations

• ¹ National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
• ² Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ³ Department of Medicine, University of Washington, Seattle, WA, USA.
• ⁴ National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁵ Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD, USA.
• ⁶ Office of Biostatistics Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁷ National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. [email protected].